Pandemic Influenza Preparedness and Response Plan

Pandemic Preparedness and Response National Control Plan 2006
South Korea English PDF
National

AI-Generated Document Summary

Objectives

South Korea’s 2006 Pandemic Influenza Preparedness and Response Plan provides a comprehensive, phase-based framework to prevent or delay pandemic emergence, contain transmission where possible, minimise illness, deaths and wider social disruption, sustain essential services, and support recovery after the pandemic.The framework combines the World Health Organization’s six pandemic phases with four National Security Council disaster levels: Concern, Caution, Alert and Severe.

  • Strengthen national preparedness infrastructure, including command and control, risk communication, surveillance, healthcare delivery, laboratory diagnosis, vaccines, antivirals, public-health measures, education and research.
  • Detect novel influenza viruses and epidemic signals early; identify affected groups, transmission patterns and circulating strains; and rapidly isolate, investigate and contain cases or clusters.
  • Protect healthcare capacity by planning for patient surges, triage, isolation, treatment hospitals, intensive care, respiratory support, staff protection and continuity of essential services.
  • Minimise infection and deaths through vaccine development, domestic production capacity, stockpiling, prioritisation and safe administration, alongside prioritised antiviral treatment and prophylaxis.
  • Apply proportionate public-health measures, including quarantine, isolation, contact management, travel controls, school closures, restrictions on gatherings, social distancing, respiratory hygiene and public education.
  • Address legal and ethical questions in advance, including movement restrictions, use of unlicensed vaccines, compulsory vaccination of first responders, compensation and fair allocation of scarce vaccines, antivirals, hospital beds, intensive-care capacity and respirators.

Planning assumptions are intended to estimate resource needs rather than predict exact case numbers.Under a 30% gross attack-rate scenario over an eight-week first wave, the plan estimated approximately 54,594 deaths, 235,592 hospitalisations and 8,840,418 outpatient visits nationally.These estimates inform planning for healthcare workers, medical supplies, hospital beds and socioeconomic disruption.

Implementation

Implementation relies on coordinated central and local government action, phase-specific escalation, multi-sector preparedness, operational guidance and continuous review.The Ministry of Health and Welfare is the primary agency, while the Korea Centers for Disease Control and Prevention carries out ministerial directions and disseminates alerts through the National Infectious Disease Control System.For domestic outbreaks, pandemic phase determination draws on Influenza Advisory Committee expert opinion, while the National Security Council level reflects the higher applicable overseas or domestic risk level.

  • Coordinate national decisions through the Ministry of Health and Welfare, National Security Council, Central Safety Management Committee, Central Disaster and Safety Countermeasures Headquarters, Pandemic Advisory Committee and relevant ministries, local authorities and professional bodies.
  • Operate risk communication through a central situation room, 24-hour contact systems, designated spokespersons, briefings, hotlines including 1339, web-based updates and communication networks linking government, healthcare workers, the public and international partners.
  • Maintain surveillance through the Korea Influenza Surveillance Scheme, involving approximately 700 reporting facilities, supplemented by school absenteeism monitoring, emergency-room syndromic surveillance, laboratory networks and specialist reporting systems.
  • Use reporting thresholds, case definitions, daily and weekly reporting, laboratory confirmation and trend analysis to assess influenza-like illness, respiratory syndromes, outbreaks, virus strains, hospitalisation and mortality.
  • Deploy Rapid Response Teams to verify suspected cases, investigate epidemiological links, collect and transport specimens, manage contacts, support containment and report field findings to the Korea Centers for Disease Control and Prevention.
  • Prepare hospitals to designate treatment and isolation facilities, establish emergency response committees, apply triage and infection-control protocols, cohort patients, train staff, postpone non-essential admissions and expand capacity when necessary.
  • Manage community and border risks through traveller screening, quarantine questionnaires, thermal screening, temporary isolation, safe patient transport, contact tracing, home isolation and phase-appropriate controls on travel and gatherings.
  • Stockpile and distribute antivirals, personal protective equipment, diagnostic reagents and vaccines; track recipients; monitor adverse reactions and antiviral resistance; and revise priorities in response to epidemiological evidence and supply constraints.
  • Train healthcare workers, public-health personnel, schools, local authorities and community partners through education materials, tabletop exercises, field exercises and annual avian-influenza risk-management exercises.

The delivery model extends beyond health services to education, transport, communications, electricity, water, public security, the military, businesses, schools, veterinary and agricultural organisations, and international bodies.International information exchange includes the World Health Organization, World Organisation for Animal Health, Food and Agriculture Organization, diplomatic missions and other surveillance partners.

Preparedness is designed to be iterative: exercises, internal crisis assessment meetings, surveillance findings and operational experience are used to identify weaknesses, revise plans and guidance, assess legal needs and improve response capability.The supplied material identifies substantial resource needs but does not specify a consolidated budget, financing model, funding source or quantified funding gap.

Monitoring & Evaluation

The plan establishes a layered monitoring and evaluation system linking World Health Organization pandemic phases, national disaster-alert levels, surveillance data, operational reporting, exercises and plan review. It uses surveillance both to detect and characterise influenza transmission and to guide escalation, resource allocation, containment measures, vaccination and antiviral priorities.

  • Monitor influenza-like illness, virus isolation, circulating strains, affected groups, unusual increases and novel subtypes through the Korea Influenza Surveillance Scheme, involving approximately 700 healthcare facilities, of which 600 report weekly and 100 report daily to the Korea Centers for Disease Control and Prevention.
  • Apply an influenza-like-illness definition of fever above 38°C with cough or sore throat, calculate rates per 1,000 inpatients, and use 7.5 cases per 1,000 as the weekly outbreak threshold.
  • Require weekly reporting of total patients and influenza-like-illness cases, daily web-based reporting by daily sentinel facilities and emergency rooms, and individual reporting of critically ill hospitalised patients through the emergency-room system.
  • Supplement routine surveillance through school absenteeism monitoring in 70 schools, acute respiratory syndrome monitoring in 125 emergency-care facilities, specialist networks and syndromic surveillance, particularly where surges disrupt reporting by smaller facilities and private practices.
  • Classify pandemic-influenza cases as suspected, probable or confirmed under a standard case definition based on World Health Organization criteria, and disseminate the definition to clinicians through professional associations.
  • Use laboratory reporting, confirmatory testing, subtype and antigenic characterisation, genetic analysis, antiviral-susceptibility testing and referral of isolates to World Health Organization collaborating centres to support national and global surveillance.
  • Report rapid antigen-test results through a web-based system on a monthly basis, provide feedback on results, and refer qualifying isolates and unconfirmed samples for national confirmation and characterisation.
  • Monitor emerging subtypes, animal-to-human risk, human cases, person-to-person transmission, cluster size and geographical spread; use these findings to assess progression from limited clusters to sustained community transmission.
  • Apply World Health Organization phases internationally and determine domestic phases through expert opinion from the Influenza Advisory Committee; set the National Security Council alert level according to the higher foreign or domestic phase.
  • Use phase-specific reporting and response actions, including rapid detection and notification, isolation of new cases, investigation of additional cases, containment or delay of spread, and assessment of sustained transmission.
  • Shift during Phase 6 from individual-case reporting and active contact monitoring towards measurement of pandemic impact through daily hospitalisations, deaths and local incidence levels.
  • Monitor exposed contacts through the longest incubation period, including active checks on the second and fifth days after exposure, with extension where necessary.
  • Maintain patient, mortality and hospital-surge monitoring so that a central situation room can identify daily patient numbers, critically ill patients and influenza deaths, while integrating notifiable-disease, sentinel, emergency-room and syndromic surveillance outputs.
  • Track antiviral recipients, antiviral resistance and adverse effects, and monitor vaccination recipients and adverse reactions, including acute surveillance of post-vaccination events during a pandemic.
  • Use model-based indicators, including outpatient visits, hospitalisations, severe illness and deaths, to estimate healthcare-worker, supply and bed requirements. Under a 30% gross attack-rate assumption, national planning estimates include 54,594 deaths, 235,592 hospitalisations and 8,840,418 outpatients.
  • Conduct internal crisis-assessment and consultation meetings to determine, revise and disseminate emergency alerts, with prior consultation with national crisis-management bodies for government-wide orange or red alerts.
  • Require Rapid Response Teams to investigate suspected cases, collect and transport specimens, maintain epidemiological-investigation records, assess outbreaks and report field findings through coordinating structures to the Korea Centers for Disease Control and Prevention.
  • Evaluate preparedness through continuous plan review, tabletop exercises and annual avian-influenza risk-management exercises combining tabletop and field elements; exercises assess timely crisis decisions, inter-agency coordination, local and facility preparedness, and problems involving regulations, budgets and resource management.
  • Use hospital-level preparedness checklists and simulation exercises to record whether committees, coordinators, written plans and surveillance arrangements are in place, and monitor staff in isolation wards for fever and respiratory symptoms through self-assessment and regular weekly evaluation.
  • Reassess reported patients requiring follow-up within 48 hours through Public Health Centres, including by telephone where appropriate, and use clinical triage, reassessment and warning-sign monitoring to determine home care, outpatient care, observation or hospitalisation.

Although the framework contains extensive surveillance, reporting, review and operational-assessment mechanisms, it generally does not specify a consolidated set of performance targets, routine reporting timetable, independent audit process or separate formal accountability framework.

Costing & Financing

The plan identifies substantial resource requirements and economic risks from pandemic influenza, but does not provide a quantified budget, financing model, funding allocation, funding source, funding gap or monetary economic assumption.

  • Recognise that previous pandemics generated high direct healthcare costs and potentially very large indirect costs through socioeconomic disruption and recovery, while demand may exceed existing healthcare capacity and disrupt medical resources.
  • Use impact estimates to approximate requirements for healthcare workers, medical supplies, hospital beds and broader socioeconomic planning, rather than as precise forecasts of patient numbers.
  • Plan for resource-intensive preparedness activities, including antiviral and personal protective equipment stockpiles, domestic vaccine production, laboratory expansion, isolation and critical-care capacity, hospital surge arrangements, training, exercises, communications systems and mass immunisation.
  • Manage scarce antivirals and vaccines through predefined priority groups, distribution tracking, safety monitoring and review of priorities as epidemiological conditions change.
  • Account for operational capacity constraints, including projected hospitalisation of approximately 235,600 people under a 30% gross attack rate, around 9,000 intensive-care patients at peak, and respiratory-support needs for about half of intensive-care patients.
  • Record reported 2006 capacity of 382,000 hospital beds, including 12,800 critical-care beds, approximately 5,900 respirators, and 516 designated isolation beds at 38 hospitals; planned additions included 80 negative-pressure beds and 320 general isolation beds over four years.
  • Recognise that pandemic vaccine production may take four to six months after onset and that estimated global manufacturing capacity of around 300 million doses would cover roughly 5% of the world population, creating a supply constraint rather than a stated financial estimate.
  • Use cost-benefit analysis as a consideration for antiviral stockpiling, particularly for predefined priority groups, while the source does not quantify medicine prices or stockpile costs.
  • Consider economic disruption associated with school and kindergarten closures, including childcare burdens and impacts on economic activity, without providing a monetary estimate or financing mechanism.

Quantitative figures in the plan are planning assumptions, capacity estimates or vaccine-demand estimates rather than budgeted expenditure. For example, it estimates approximately 5.5 million vaccine doses for high-risk medical groups but assigns no monetary value.

Document Viewer